It was a busy month. ECTRIMS (European Committee for Treatment and Research in Multiple Sclerosis Congress; October 7 – 10, 2015 in Barcelona) came and went, with insight and data offered on existing and new therapies.

Highlight! Less vitamin D and melatonin bad for multiple sclerosis Multiple sclerosis relapse risk influenced by melatonin levels Melatonin could help treat multiple sclerosis Melatonin Linked to Seasonal Relapses of Multiple Sclerosis

Vitamin D research was once again a recurring news story this month, with more studies linking lack of vitamin D to MS. Also widely reported was the news Novartis bought GlaxoSmithKline’s remaining rights to Ofatumumab, an investigational multiple sclerosis medicine, for up to $1 billion. Highlight! Gene study finds link between multiple sclerosis and low vitamin D Gene study backs up link between vitamin D and multiple sclerosis risk Low levels of vitamin D may cause multiple sclerosis Vitamin D deficiency direct cause of multiple sclerosis (MS): Study

Because of the summer holidays, less positive news has filtered through. Either way, enjoy, and hopefully more next month! Research Gene Regulating Treatment Response in Multiple Sclerosis Identified New Study Evaluates The Role of MRI in Monitoring MS Progression Multiple Sclerosis Nano-Drugs in Liposomes Could Treat Multiple Sclerosis Altered Immune Cells in Relapsing Remitting Multiple Sclerosis Patients Cause Reduced Immune Capacity MS Study Uses Findings on Quality of Life Issues To Develop New Confidence-Building Intervention Nutra Pharma Working on Pediatric MS Treatment Based on Venom Multiple Sclerosis News Today Identifying MS Gene Mutations Could Make Personalized Treatment Possible Multiple Sclerosis … Brain Scan To Detect Multiple Sclerosis, Other Brain Abnormalities Why medical research matters New MS Study Shows TYSABRI Improves Cognitive Impairment AB Science announces successful non futility test for…

New additions: news about MS and diet, exercise etc. More will follow soon! Highlight! Hawaii Legislature approves medical marijuana dispensaries Medical marijuana registry in Quebec called world’s first Texas Senate Approves Medical Marijuana Bill State health officials unveil new marijuana dispensary rules

Research news Miconazole and clobetasol may be effective as multiple sclerosis therapies Drug Derived From Sea Anemone Shows Promise Against Psoriasis, MS Novel Drug From Nature Shows Early Promise ‘Brainbow’ illuminates cellular connections MS Association of America releases 2015 multiple sclerosis research update B Vitamin Promising in Progressive Multiple Sclerosis Phenytoin protects against optical damage in multiple sclerosis Could Eczema Cream Be Used for Treating Multiple Sclerosis? URMC Start-up Takes Aim at Memory and Cognitive Problems Controversial stem cell treatment for multiple sclerosis Key Cytokine Discovery May Shape Future MS Treatment The UpBeat: One of the ‘super heroes’ encouraged by promising MS research Drugs that activate brain stem cells may reverse multiple sclerosis Novel Mechanism May Prevent Onset of MS in Immune Cells French firm announces multiple sclerosis drug breakthrough…